HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.

Abstract
A series of Dmt-Tic analogues with substitution on the Tic aromatic ring has been synthesized and evaluated for opioid receptor affinity and activation. Incorporation of large hydrophobic groups at position 7 of Tic did not greatly alter the delta opioid receptor binding affinities of the dipeptides whereas substitution at position 6 substantially diminished their affinity. These modified Dmt-Tic peptides showed binding affinities as low as 2.5 nM with up to 500-fold selectivity for the delta versus mu opioid receptor and proved to be delta receptor antagonists.
AuthorsD Pagé, A McClory, T Mischki, R Schmidt, J Butterworth, S St-Onge, M Labarre, K Payza, W Brown
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 10 Issue 2 Pg. 167-70 (Jan 17 2000) ISSN: 0960-894X [Print] England
PMID10673103 (Publication Type: Journal Article)
Chemical References
  • Benzamides
  • Dipeptides
  • Isoquinolines
  • Piperazines
  • Receptors, Opioid, delta
  • Tetrahydroisoquinolines
  • 2',6'-dimethyltyrosine
  • 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamide
  • 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Tyrosine
Topics
  • Benzamides (metabolism)
  • Binding, Competitive
  • Dipeptides (chemical synthesis, pharmacology)
  • Guanosine 5'-O-(3-Thiotriphosphate) (metabolism)
  • Humans
  • Isoquinolines (chemistry)
  • Piperazines (metabolism)
  • Receptors, Opioid, delta (agonists, antagonists & inhibitors)
  • Tetrahydroisoquinolines
  • Tyrosine (analogs & derivatives, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: